Karin Hohloch

1.5k total citations
40 papers, 960 citations indexed

About

Karin Hohloch is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Karin Hohloch has authored 40 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pathology and Forensic Medicine, 16 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Karin Hohloch's work include Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Karin Hohloch is often cited by papers focused on Lymphoma Diagnosis and Treatment (27 papers), Viral-associated cancers and disorders (8 papers) and Lung Cancer Treatments and Mutations (8 papers). Karin Hohloch collaborates with scholars based in Germany, Switzerland and Italy. Karin Hohloch's co-authors include Lorenz Trümper, Martin Zeitz, Thomas Schneider, Andreas Stallmach, Bernd Metzner, Michael Kneba, Jürgen Brockmöller, Nicole Stolte, Christiane Stahl‐Hennig and Ulrich Dührsen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Karin Hohloch

39 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Hohloch Germany 13 460 314 249 208 141 40 960
Nabih Azar France 19 344 0.7× 357 1.1× 245 1.0× 159 0.8× 231 1.6× 41 1.3k
Bruce G. Raphael United States 12 534 1.2× 321 1.0× 553 2.2× 127 0.6× 83 0.6× 28 972
Zale P. Bernstein United States 19 549 1.2× 571 1.8× 397 1.6× 513 2.5× 65 0.5× 60 1.6k
Neil Kogut United States 18 349 0.8× 116 0.4× 495 2.0× 135 0.6× 57 0.4× 52 914
José‐Tomás Navarro Spain 17 571 1.2× 305 1.0× 583 2.3× 66 0.3× 54 0.4× 85 964
Bernard R. Greenberg United States 19 249 0.5× 303 1.0× 554 2.2× 203 1.0× 143 1.0× 64 1.5k
Aleksandr Lazaryan United States 21 275 0.6× 142 0.5× 797 3.2× 443 2.1× 77 0.5× 103 1.7k
Patrizio Mazza Italy 22 1.1k 2.3× 516 1.6× 680 2.7× 205 1.0× 75 0.5× 98 1.8k
Gianfranco Lauletta Italy 23 208 0.5× 322 1.0× 123 0.5× 247 1.2× 382 2.7× 57 1.9k
Salvatore Berretta Italy 17 175 0.4× 157 0.5× 423 1.7× 54 0.3× 174 1.2× 45 834

Countries citing papers authored by Karin Hohloch

Since Specialization
Citations

This map shows the geographic impact of Karin Hohloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Hohloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Hohloch more than expected).

Fields of papers citing papers by Karin Hohloch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Hohloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Hohloch. The network helps show where Karin Hohloch may publish in the future.

Co-authorship network of co-authors of Karin Hohloch

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Hohloch. A scholar is included among the top collaborators of Karin Hohloch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Hohloch. Karin Hohloch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luyckx, Valérie A., et al.. (2021). Granulomatous interstitial nephritis in a patient with SARS-CoV-2 infection. BMC Nephrology. 22(1). 19–19. 17 indexed citations
2.
3.
Hohloch, Karin, Christine Windemuth-Kieselbach, Pier Luigi Zinzani, et al.. (2020). Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry. Annals of Hematology. 99(5). 1073–1079. 6 indexed citations
4.
Venzin, Reto, et al.. (2019). Cerebral salt wasting in a patient with myeloproliferative neoplasm. BMC Neurology. 19(1). 169–169. 2 indexed citations
5.
Hohloch, Karin. (2016). Radioimmunotherapy of lymphoma: an underestimated therapy option. The Lancet Haematology. 4(1). e6–e7. 2 indexed citations
6.
Hohloch, Karin, Samira Zeynalova, Bjoern Chapuy, et al.. (2016). Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma. Annals of Hematology. 95(7). 1121–1128. 2 indexed citations
7.
Kauffmann, Philipp, Wolfram Hahn, Markus Troeltzsch, et al.. (2016). Osteoblast-like cells with different embryologic origins behave differently in increasing zoledronic acid concentrations: a pilot study in pigs. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 123(1). 20–28. 3 indexed citations
8.
Hohloch, Karin, Samira Zeynalova, Gerhard Held, et al.. (2014). Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimens. Leukemia. 28(11). 2260–2263. 5 indexed citations
9.
Hohloch, Karin, et al.. (2014). Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network. European Journal of Nuclear Medicine and Molecular Imaging. 41(8). 1585–1592. 9 indexed citations
10.
11.
Hohloch, Karin, et al.. (2014). Superior vena cava syndrome caused by a malignant tumor: a retrospective single-center analysis of 124 cases. Journal of Cancer Research and Clinical Oncology. 140(12). 2129–2134. 10 indexed citations
12.
Stroux, Andrea, Jan Eucker, Karin Hohloch, et al.. (2013). Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma. Annals of Oncology. 25(1). 210–215. 41 indexed citations
13.
Hohloch, Karin, Angelika Bischof Delaloye, José Gómez‐Codina, et al.. (2011). Radioimmunotherapy Confers Long-Term Survival to Lymphoma Patients with Acceptable Toxicity: Registry Analysis by the International Radioimmunotherapy Network. Journal of Nuclear Medicine. 52(9). 1354–1360. 12 indexed citations
14.
15.
Nestle, Ursula, Klemens Scheidhauer, Karin Hohloch, et al.. (2010). Retrospective web-based multicenter evaluation of 18F-FDG-PET and CT derived predictive factors. Nuklearmedizin - NuclearMedicine. 50(1). 39–47. 6 indexed citations
16.
17.
Chapuy, Bjoern, Karin Hohloch, & Lorenz Trümper. (2007). Yttrium 90 ibritumomab tiuxetan (Zevalin®): A new bullet in the fight against malignant lymphoma?. Biotechnology Journal. 2(11). 1435–1443. 7 indexed citations
18.
Menges, Markus, et al.. (2002). Lichen planus with Oesophageal Involvement. Digestion. 65(3). 184–189. 24 indexed citations
19.
Schneider, Thomas, Karin Hohloch, Nicole Stolte, et al.. (1999). Rapid mucosal CD4+ T-cell depletion and enteropathy in simian immunodeficiency virus–infected rhesus macaques. Gastroenterology. 116(5). 1115–1123. 121 indexed citations
20.
Zeitz, Martin, et al.. (1998). HIV/SIV Enteropathy. Annals of the New York Academy of Sciences. 859(1). 139–148. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nabih Azar Breakdown of academic impact, for papers by Bruce G. Raphael Breakdown of academic impact, for papers by Zale P. Bernstein Breakdown of academic impact, for papers by Neil Kogut Breakdown of academic impact, for papers by José‐Tomás Navarro Breakdown of academic impact, for papers by Bernard R. Greenberg Breakdown of academic impact, for papers by Aleksandr Lazaryan Breakdown of academic impact, for papers by Patrizio Mazza Breakdown of academic impact, for papers by Gianfranco Lauletta Breakdown of academic impact, for papers by Salvatore Berretta
Rankless by CCL
2026